PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93025C00018Development of monoclonal antibodies to — Ampersand Biosciences LLC

Ampersand Biosciences LLC holds $1.7M across 4 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. Competition previously drew 6 offers. Set-aside status: Unrestricted. Recompete timing centers on the May 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Niaid
Awarding office
Ampersand Biosciences LLC
Recipient
May 31, 2027
PoP end
$600K
Obligated
$600K
Potential
541714
NAICS
AN11
PSC
Unrestricted
Set-aside
6 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75N93025C00018
AgencyNational Institutes Of Health Niaid
Awarding officeNational Institutes Of Health Niaid
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentAmpersand Biosciences LLC
CAGE79VC0
UEIHLWQXLFM7JR8
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11
Place of performanceLAKE CLEAR NY
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationPHS 2025-1
PoP startJun 1, 2025
PoP end (current)May 31, 2027
Obligated$600K
Current value$600K
Potential value$600K

DEVELOPMENT OF MONOCLONAL ANTIBODIES TO CHEMOKINES IN THE FERRET MODEL OF RESPIRATORY DISEASE. is a federal Unrestricted award for National Institutes Of Health Niaid held by Ampersand Biosciences LLC. Estimated value $600K ($600K obligated). Current period of performance ends May 31, 2027. Last award drew 6 bidders. Place of performance: LAKE CLEAR NY. Related solicitation PHS 2025-1.

DEVELOPMENT OF MONOCLONAL ANTIBODIES TO CHEMOKINES IN THE FERRET MODEL OF RESPIRATORY DISEASE.

Recompete timing

Public
● Expiring in 246 days

Current PoP ends May 31, 2027 (246 days remaining). Agencies typically plan 12–18 months ahead — at 8.1 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75N93025C00018? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Ampersand Biosciences LLC — $1.7M obligated across 4 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$1.7M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
75N93024C00087
FURTHER CHARACTERIZATION AND VALIDATION OF MONOCLONAL ANTIBODIES TO STUDY RESPIRATORY
$1.1M
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N93025C00018?

75N93025C00018 (Development of monoclonal antibodies to) is a National Institutes Of Health Niaid award with a potential value of $600K, currently held by Ampersand Biosciences LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93025C00018?

National Institutes Of Health Niaid awarded 75N93025C00018 to Ampersand Biosciences LLC (potential $600K).

Who is the incumbent on 75N93025C00018?

Ampersand Biosciences LLC is the incumbent with $1.7M across 4 related awards in SCOUT’s public footprint. The current period of performance ends May 31, 2027.

When does Ampersand Biosciences LLC’s 75N93025C00018 come up for recompete?

SCOUT tracks a period-of-performance end of May 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N93025C00018? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N93025C00018